Background/Aims: This study aimed to investigate whether exogenous hydrogen sulfide (H 2 S) confered cardiac protection against high glucose (HG)-induced injury by inhibiting NLRP3 inflammasome activation via a specific TLR4/NF-κB pathway. Methods: H9c2 cardiac cells were exposed to 33 mM glucose for 24 h to induce HG-induced cytotoxicity. The cells were pretreated with NaHS (a donor of H 2 S) before exposure to HG. Cell viability, cell apoptosis, intracellular reactive oxygen species (ROS), mitochondrial membrane potential (MMP), and TLR4, NF-κB, NLRP3 inflammasome, IL-1β, IL-18 and caspase-3 expression were measured by standard methods. Results: H 2 S attenuated HG-induced cell apoptosis, ROS expression and loss of MMP and reduced the expression of NLRP3, ASC, pro-caspase-1, caspase-1, IL-1β, IL-18 and caspase-3. In addition, H 2 S inhibited the HG-induced activation of TLR4 and NF-κB. Furthermore, NLRP3 inflammasome activation was regulated by the TLR4 and NF-κB pathway. Conclusion: The present study demonstrated for the first time that H 2 S appears to suppress HG-induced cardiomyocyte inflammation and apoptosis by inhibiting the TLR4/ NF-κB pathway and its downstream NLRP3 inflammasome activation. Thus H 2 S might possess potential in the treatment of diabetic cardiomyopathy.
Introduction
Diabetic cardiomyopathy (DCM) is the leading cause of mortality among diabetic patients [1, 2] . A pervasive feature of DCM and probably one of its major causes, is the chronic, low-level state of systemic and sterile inflammation. Previous studies from our group have reported a definite association between DCM and inflammation [3] . And hyperglycemia, as the major feature of diabetes, can cause cardiac contractile and diastolic dysfunction by activation of oxidative stress, inflammation, and apoptosis.
Toll-like receptors (TLRs) are pattern recognition receptors, playing an important role in the activation of innate and adaptive immune responses [4] . Activation of TLRs can trigger signaling cascades with release of several inflammatory cytokines [5] . In diabetic patients, there is a significant increase of TLR4 expression, as well as an increase in levels of endogenous ligands and their activated downstream signaling cascades, such as NF-κB signaling [6, 7] . And knockdown of TLR4 can attenuate NF-κB activity and expression of inflammatory cytokines such as interleukin (IL)-1, IL-6 and tumor necrosis factor (TNF)-α in diabetes [8] . So the TLR4 is supposed to play a predominant role in high glucose (HG)-induced inflammation.
The nucleotide-binding domain, leucine-rich-containing family, pyrin domaincontaining-3 (NLRP3) inflammasome has emerged as an important regulator of inflammation in metabolic disorders [9] . It consists of apoptosis-associated speck-like protein containing a caspase recruitment domain (ASC) and caspase-1.NF-κB is the traditional priming signal for the transcription of the NLRP3 gene [10] . And the stimulation of NLRP3 inflammasome triggers caspase-1 activation and subsequently promotes the cleavage processing and secretion of pro-inflammatory cytokine IL-1β and IL-18 [11] . Previous studies showed that inhibition of NLRP3 significantly alleviates DCM [12] . However, whether the cardiac TLR4-NF-κB-NLRP3 pathway is involved in HG-induced cardiomyocyte injury remains unknown.
Hydrogen sulfide (H 2 S) is synthesized from cysteine by cystathionine gamma lyase(CSE) and other naturally occurring enzymes. Along with nitric oxide(NO) and carbon monoxide(CO), H 2 S forms part of a group of biologically active gases that are termed gasotransmitters or gasomediators.H 2 S levels are decreased in diabetic patients and diabetic rats treated with streptozotocin [13] . H 2 S is presented to be an important cardioprotective agent in various studies [14] [15] [16] [17] . Guo et al. reported that H 2 S could protect against doxorubicin-induced inflammation and cytotoxicity by inhibiting p38MAPK/NF-κB pathway in myocardium [18] . In diabetic models, H 2 S was reported to protect cardiomyocyte from inflammation and cell death [19, 20] . Our previous study also demonstrated that exogenous H 2 S protected H9c2 cardiomyocytes against HG-induced injury by inhibiting inflammatory pathway [3] . And in this study, we try to investigate whether exogenous H 2 S shows cardiac protection against HG-induced injury by inhibiting NLRP3 inflammasome signaling, in particular TLR4-NF-κB pathway.
purchased from Kang Chen Biotech (Shanghai, China). TAK-242 (inhibitor of TLR4) was supplied by Life Tech (Carlsbad, CA, USA). Si-RNA of NLRP3 was purchased from Ribobio Biotech (Guangzhou, China). The H9c2 embryonic rat cells were supplied by the Sun Yat-Sen University Experimental Animal Center (Guangzhou, China).
H9c2 cell culture
H9c2 cardiomyocytes were cultured in DMEM medium supplemented with 10% FBS at 37℃ under an atmosphere of 5% CO 2 . To explore the protective effect of H 2 S on the HG-induced injury, cells were pretreated with 400 μM NaHS for 30 min prior to HG treatment, according to previous studies [18, [21] [22] [23] . To confirm the role of TLR4-NF-κB-NLRP3 pathway in HG-induced cardiac injury, 5μM TAK-242 (inhibitor of TLR4) was co-treated with HG, while 10 μM BAY11-7082 (inhibitor of NF-κB) was pretreated for 1 h.
RNA interference
H9c2 cells were transfected at 70% confluence using Lipofectamine transfection reagent (Life Technologies, Carlsbad, USA), and siRNA against NLRP3 (Ribo Biotechnology, Shanghai, China, sense, 5′-GCUUCAGCCACAUGACUUUTT -3′, and antisense, 5′-AAAGUCAUGUGGCUGAAGCTT -3′) or a physiologically irrelevant negative control siRNA (sense, 5′-UUC UCC GAA CGU GUC ACG UTT-3′, and antisense, 5′-ACG UGA CAC GUU CGG AGA ATT-3′). Each dried-down siRNA was dissolved in nuclease-free water to achieve a final concentration of 20 μM. Then 5μL siRNA (20 μM) and 5 μL Lipofectamine were added to a 500 μL buffer system. The mixes were kept at room temperature for 30 min to form complexes, and equal aliquots were then added into one of the wells of a 6-well plate. The cultures were incubated at 37°C in a 5% CO 2 incubator. The medium was replaced after 12 h with DMEM that did not contain either a siRNA or the transfection reagent. Cells were collected at 12 h for analyses.
Cell viability assay
After H9c2 cells were cultured in 96-well plates and received different treatments, 10 μL CCK-8 solution was added to each well at a 1/10 dilution, followed by a further 2 h incubation in the incubator. Absorbance was measured at 450 nm with a microplate reader (Mutiskan MK3 Miicroplate reader, Thermo Fisher Scientific Inc, USA). The mean optical density (OD) of five wells in the indicated groups was used to calculate the percentage of cell viability according to the formula below: percentage of cell viability = OD treatment group/ OD control group×100%. Experiments were repeated 3 times.
Assessment of apoptosis
Morphological changes of apoptosis, such as chromosomal condensation and fragmentation in the nuclei of H9c2 cells, could be observed by Hoechst 33258 staining. After different treatments, H9c2 cells were fixed with 4% paraformaldehyde in phosphate buffered saline for 10 min. After staining with 5 mg/L Hoechst 33258 for 30 min, the cells were visualized under a fluorescent microscope (BX50-FLA; Olympus, Tokyo, Japan).
Measurement of intracellular reactive oxygen species (ROS)
After different treatments, DCFH-DA (10 μM) in FBS-free medium was added to the slides and the cells were incubated for a further 30 min at 37°C. The slides were washed three times with FBS-free DMEM medium and fluorescence was measured over the entire field of vision using a fluorescent microscope connected to an imaging system (BX50-FLA; Olympus, Tokyo, Japan). Mean fluorescence intensity (MFI) from three random fields was analyzed using Image J 1.41 software (National Institutes of Health, Bethesda, MD, USA).
Measurement of mitochondrial membrane potential (MMP)
MMP was measured using the fluorescent cell-permeable dye Rh123 that preferentially enters mitochondria based on the highly negative MMP. Depolarization of MMP results in the loss of Rh123 from the mitochondria and a decrease in intracellular fluorescence. In the present study, Rh123 (100 mg/l) was added to medium for 45 min at 37°C. Rh123 fluorescence was measured over the entire field of vision using a fluorescent microscope connected to an imaging system (BX50-FLA; Olympus Tokyo, Japan). The MFI of Rh123 from five random fields was analyzed with Image J 1.41 software, with MFI taken as an index of MMP. Western blot assay After the indicated treatments, H9c2 cells were harvested and lysed, and the homogenate was centrifuged at 12,000 rpm for 10min at 4℃. The total protein in the supernatant was quantitated with a BCA protein assay kit. Total protein (30 μg from each sample) was separated by 12% sodium dodecyl sulfatepolyacrylamide gel electrophoresis (SDS-PAGE). The protein in the gel was transferred to a polyvinylidene difluoride (PVDF) membrane. The membrane was blocked with 5% free-fat milk in TBS-T for 1h at room temperature, and then incubated with primary antibodies specific to TLR4 (1:1000), p-p65 (1:1000), t-p65 (1:1000), NLRP3 (1:1000), ASC (1:500), caspase-1 (1:1000), pro-caspase-1 (1:1000), caspase-3 (1:1000) or GAPDH (1:10000) with gentle agitation at 4℃ overnight and subsequently incubated with the secondary antibodies for 1.5h at room temperature. Following three washes with TBS-T, membranes were developed using enhanced chemiluminescence and exposed to X-ray films. To quantify protein expression, the X-ray films were scanned and analyzed with ImageJ 1.41 software (National Institutes of Health, USA).
ELISA for detection of IL-1β and IL-18 in culture supernatant
After indicated treatments, levels of IL-1β and IL-18 in cell lysates were measured by ELISA according to the manufacturer's instruction. The experiments were performed at least 3 times.
Statistical analyses
All data were presented as the mean ± standard error (SE). Differences between groups were analyzed by one-way analysis of variance (ANOVA) with SPSS 13.0 (Chicago, IL, USA). P < 0.05 was considered to be significantly different.
Results

HG induced apoptosis and inflammation in H9c2 cells
We examined the effect of HG with different levels in cardiac cells first. CCK-8 analysis showed significant decrease of cell viability in 33 and 44 mM glucose (Fig. 1A , p < 0.01). Further, we detected the effect of HG with different duration, and the protein level of caspase-3, an important regulator of apoptosis, markedly elevated from 6 to 24 h (Fig. 2B , p < 0.05~ p < 0.01). Hoechst result showed increased apoptosis in HG group, presenting as nucleus DNA damage (Fig. 1C) and loss of MMP (Fig. 1D) . Similarly, HG elevated the level of ROS compared with control (Fig. 1E) .
Coincident with exacerbated apoptosis in HG, ELISA data revealed enhanced expression of pro-inflammatory cytokines with HG exposure. As shown in Fig. 1F -G, the level of IL-1β and IL-18 increased with a concentration-dependent manner in 22mM to 44mM HG (p < 0.01). In keeping with our previous study [19] and clinical situation, 33 mM HG treatment for 24 h was chosen as our model to mimic the hyperglycemia.
The increased expression of NLRP3 inflammasome, TLR4 and NF-κB were induced by HG NLRP3 inflammasome consists of three subunits, NLRP3, ASC and caspase-1. Caspase-1 is transformed from pro-caspase-1. HG treatment led to a remarkable time-dependent increase in the expression of these three subunits ( Fig. 2A-C , p < 0.05 ~ p < 0.01), as well as the amount of pro-caspase-1 (Fig. 2D, p < 0.05) . Likewise, two important intracellular signal pathways, TLR4 and NF-κB, were both activated by HG in 12 to 24h (Fig. 2E-F , p < 0.05 ~ p < 0.01).
Exogenous H2S protected against HG-induced apoptosis and inflammation
Then we investigated the effect of H 2 S on HG-induced injury. With pretreatment of NaHS for 30 min, cell viability was considerably increased (Fig. 3A , p < 0.05) and the expression of caspase-3 was dampened (Fig. 3B, p < 0.05) . Similarly, H9c2 cells presented less apoptotic rate (Fig. 3C , p < 0.01) and decreased level of ROS (Fig. 3F , p < 0.01) with NaHS pretreatment, compared with HG group. Loss of MMP was also significantly ameliorated (Fig. 3D , p < 0.05) in HG+NaHS group. 
and ROS (E) were carried out. H9c2 cells were cultured in glucose with various concentrations, and protein levels of IL-1β (F) and IL-18 (G) were detected by ELISA. Data were presented as means ± SEM, from 3 independent experiments.*p < 0.05 vs. control, **p < 0.01 vs. control. Furthermore, we examined the expression of pro-inflammatory cytokines in HG+NaHS group. Pretreatment of H9c2 cells with NaHS attenuated the protein levels of IL-1β and IL-18 ( Fig. 3F-G , p < 0.01).Treatment with NaHS alone didn't show any effect on H9c2 cells (Fig.  3A-G) .
NaHS alleviated HG-induced activation of NLRP3 inflammasome, TLR4 and NF-κB
In HG + NaHS group, the expression of NLRP3 inflammasome was markedly reduced compared with HG group (Fig. 4A-D , p < 0.05 ~ p < 0.01). The increase of TLR4 and NF-κB pathway induced by HG was also attenuated by NaHS (Fig. 4E-F , p < 0.01).Treatment with NaHS alone didn't show any effect on H9c2 cells (Fig. 4A-F) .
NLRP3 inflammasome expression in HG-treated cardiac cells was suppressed by gene silencing
To explore the role of NLRP3 in HG-induced injury, we inhibited the expression of NLRP3 by NLRP3-siRNA. The protein level of NLRP3 in H9c2 cells transfected with NLRP3-siRNA was lower than the vehicle (Fig. 5A, p < 0.05) . After inhibiting the expression of NLRP3, the protein levels of activated ASC and caspase-1 induced by HG simultaneously decreased compared with HG group (Fig. 5B-C , p < 0.01).NLRP3-siRNA treatment alone didn't cause alteration of the ASC and caspase-1 expression (Fig. 5B-C) .
NLRP3 inflammasome was involved in apoptosis and inflammation induced by HG
Then we investigated the contribution of NLRP3 to HG-induced apoptosis.CCK-8 assay presented improved cell viability (Fig. 6A, p < 0.05) and Western blot result showed a marked reduction of caspase-3 expression (Fig. 6B , p < 0.01)in H9c2 cells with NLRP3 inhibition. In keeping with this observation, we also found significant decrease in apoptotic rate (Fig. 6C, 
TLR4 and NF-κB mediated the HG-induced NLRP3 inflammasome activation
Above observation presented that HG activated the expression of TLR4, NF-κB and NLRP3 inflammsome, and further we tried to figure out the association among TLR4, NF-κB and NLRP3 inflammsome. Pretreatment of cells with TLR4 inhibitor TAK-242 inhibited the production of lipopolysaccharide-induced inflammatory mediator by binding to the intracellular domain of TLR4. The protein level of phosphorylated NF-κB was decreased in HG+TAK-242 group than in HG group (Fig. 7A, p < 0.01) .There was no difference in phosphorylated NF-κB expression between TAK-242 group and control group (Fig. 7A) .
Moreover, we inhibited the expression of NF-κB by BAY11-7082, which specifically abrogated NF-κB DNA binding. Treating with BAY11-7082, the protein level of NLRP3 decreased as compared with HG group (Fig. 7B, p < 0.01) . The above data prompted that TLR4-NF-κB pathway may induce activation of NLRP3 in HG-treated cardiac cells. No altered expression of NLRP3 was detected in BAY11-7082 group (Fig. 7B ).
Discussion
In this study, we aimed to explore the effect and underlying mechanism of exogenous H 2 S in HG-induced cardiac injury. As shown in Fig. 8 , the results presented that 1) 33 mM HG caused significant exacerbated apoptosis and inflammation in H9c2 cells; 2) NLRP3, TLR4 and NF-κB pathway were all activated in HG-treated cardiac cells; 3)400 μM NaHS protected against hyperglycemia-induced cardiomyocyte apoptosis and inflammation; 4) the protective effect of H 2 S was associated with its ability to inhibit the activation of NLRP3 inflammasome via TLR4/ NF-κB pathway.
H 2 S, an endogenously-generated gas, has been shown to elicit cardioprotective effect in various injury models [24] . In this study, we demonstrated that exogenous H 2 S protected cardiomyocytes against HG-induced inflammation and apoptosis, presenting as ameliorated apoptotic rate, dampened activation of ROS, alleviation in loss of MMP and decreased expression of pro-inflammatory cytokines. Similarly, a study in vivo presented that intraperitoneal or oral administration of H 2 S reduced myocardial hypertrophy and reduced the degree of fibrosis [15] . Several studies have proved that H 2 S could significantly reduce oxidative stress and hence improve cell viability [25, 26] . These findings indicate that H 2 S is a potential therapeutic agent for the treatment of DCM.
Furthermore, we tried to investigate the mechanisms underlying the protective effect of H 2 S in DCM. Actually, it is governed by multiple signaling pathways. Our previous studies found that H 2 S alleviates HG-induced cardiotoxicity by inhibiting leptin signaling and mitogen-activated protein kinase [3, 27] . Meanwhile, a whale of studies demonstrated the protection of H 2 S in diabetic target organs via anti-inflammation [13, 15, 24] . In the present study, treatment of NaHS remarkably alleviated the activation of TLR4 and NF-κB signaling, revealing that TLR4 and NF-κB signaling may be important in H 2 S protection.
TLR4 expression markedly increases in various diabetic models, paralleling with enhanced cell injury [28] [29] [30] [31] . In diabetic mice, level of TLR4 significantly elevated [32] . Moreover, treatment with TLR4-siRNA minimized apoptosis in myocardial tissues [32] . Similarly, the present study showed a time-dependent increase of TLR4 expression in HGtreated cardiomyocytes, coincident with the exacerbated inflammation and cell death. In muscle biopsies of T2DM patients, increased TLR4 expression was found to cause activation of NF-κB signaling with the release of pro-inflammatory cytokines [33] . As the dominant isoform of TLRs in cardiomyocytes, TLR4 can interact with cytosolic adapters. Then it induces proteasomal degradation of the inhibitors of NF-κB (IκBs), enabling NF-κB translocation into the nuclei [34] . An in vivo study revealed that H 2 S protected against cellular injury via inhibition of NF-κB activation [35] . In our study, blockage of TLR4 activation considerably ameliorated NF-κB activation. Moreover, TLR4 antagonists, eritoran, and geldanamycin resulted in attenuated myocardial inflammatory responses including reduced NF-κB nuclear translocation and decreased gene transcript of multiple pro-inflammatory cytokines [36, 37] . On above observation, we supposed an important role of TLR4 in H 2 S protection against hyperglycemia-induced NF-κB signal activation and cardiac injury.
Our data also presented that activation of NLRP3 inflammasome led to increased expression of IL-1β and IL-18 in hyperglycemia, along with permeabilization of plasma membrane and nucleus DNA damage. Furthermore, NLRP3 silencing significantly attenuated the HG-induced activation of IL-1β and IL-18, as well as cell death. In vivo, HG-induced excessive activation of NLRP3 inflammasome was observed, as well as cardiac dysfunction, fibrosis and disorganized ultrastructure [12] . NLRP3 inflammasome has been identified in a wide range of cells including cardiomyocytes [38] . NLRP3 is reported to be held inactive in cytoplasm. Once it is freed, subsequent oligomerization leads to the recruitment of procaspase-1, then promoting autocleavage and activation [39] . Active caspase-1 can finally process IL-1β and IL-18, serving as enhancers of multiple inflammatory responses. In the diabetic state, activation of pro-inflammatory cytokines by hyperglycemia leads to the persistent inflammation in myocardium, which contributes to diabetic cardiac dysfunction [40] . The result supported our conjecture that NLPR3 inflammsome plays an important role in HG-induced inflammation and apoptosis in myocardium.
In light of the pivotal role of NLRP3 in DCM, we tried to figure out potential signal pathways involved in NLRP3 inflammasome activation. Using the inhibitors of TLR4 and NF-κB, we found that in HG-treated cardiac cells, inhibiting TLR4 signal reduced the expression of NF-κB, while blockage of NF-κB downregulated NLRP3 expression. Similarly, in another study of monocytes, siRNA knockdown of TLR4 led to decreased NF-κB activity and IL-1β release [41] . Moreover, NF-κB has been reported to enhance the expression of NLRP3 and IL-1β, and NF-κB sites in NLRP3 promoter have been identified [10, 42, 43] . And third, NF-κB increases the amount of thioredoxin interacting protein and oxidized mitochondrial DNA, which might serve as ligands of NLRP3 [44, 45] . Based on above results, NLRP3 inflammasome activation is supposed to be a key outcome of TLR4/NF-κB stimulation in DCM.
However, no specific NLRP3 antagonist has been identified yet, and increasing efforts are being invested as a result of successful blockade of downstream effectors IL-1β and caspase-1 in DCM. Recent evidence reported that intravenous IgG therapy protected neurons in stroke through a mechanism involving suppression of NLRP3 inflammasome activity [46] . In the present study, Using 400μM NaHS, we observed a downregulation of NLRP3 expression in hyperglycemia, paralleling with ameliorated myocardial condition. These data underscores the potential benefit of exogenous H 2 S in blocking NLRP3 inflammasome activation for DCM.
Nowadays, several possibilities are considered to augment the beneficial effects of H 2 S in DCM: (1) stimulation of H 2 S synthesizing enzymes, (2) supplying more substrate (l-cysteine) for H 2 S synthesis, and (3) administration of exogenous H 2 S or its donors. Statins are shown to increase H 2 S level by inhibiting its metabolism [47] . Administration of SQR inhibitors can potentially inhibit H 2 S breakdown [48] . An N-mercapto-based H2S donor (NSHD)-1
